Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1187-1192

  Sun, A ^a   Wang, J T ^a   Chia, J S ^b   Chiang, Chun Ping ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Interleukin 6; Interleukin 8; Levamisole; Oral lichen planus

Indexed keywords

BIOLOGICAL MARKER; CD3 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEVAMISOLE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATORY DISEASE; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MOUTH LICHEN PLANUS; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SKIN ULCER; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; INTERLEUKIN-8; LEVAMISOLE; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; SENSITIVITY AND SPECIFICITY;

EID: 21644464021     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06497.x     Document Type: Article

References (34)

1. Scully C, El-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol 1985; 14:431-58.
2. Porter SR, Kirby A, Olsen I, Barrett W. Immunologic aspects of dermal and oral lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:358-66.
3. Hirota J, Osaki T, Tatemoto Y. Immunohistochemical staining of infiltrates in oral lichen planus. Path Res Pract 1990; 186:625-32.
4. Yamamoto T, Yoneda K, Ueta E, Osaki T. Cellular immunosuppression in oral lichen planus. J Oral Pathol Med 1990; 19:464-70.
5. Sun A, Chia JS, Chang YF, Chiang CP. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med 2002; 31:196-203.
6. Toruniowa B, Krasowska D, Koziol M et al. Serum levels of IL-6 in mycosis fungoides, psoriasis and lichen planus. Ann N Y Acad Sci 1995; 762:432-4.
7. Yamamoto T, Yoneda K, Ueta E, Osaki T. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol 1994; 78:727-35.
8. Karagouni EE, Dotsika EN, Sklavounou A. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J Oral Pathol Med 1994; 23:28-35.
9. al-Dalaan A, al-Sedairy S, al-Balaa S et al. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol 1995; 22:904-7.
10. Wang LM, Kitteringham N, Mineshita S et al. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease. Arch Dermatol Res 1997; 289:444-7.
11. Ozoran K, Aydintug O, Tokgoz G et al. Serum levels of interleukin-8 in patients with Behçet's disease. Ann Rheum Dis 1995; 54:610.
12. Zouboulis CC, Katsantonis J, Ketteler R et al. Adamantiades- Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000; 292:279-84.
13. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leuk Biol 2002; 72:847-55.
14. Berner R, Tuxen B, Clad A et al. Elevated gene expression of interleukin-8 in cord blood is a sensitive marker for neonatal infection. Eur J Pediatr 2000; 159:205-10.
15. Kanda T, Hirao Y, Oshima S et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol 1996; 77:304-7.
16. Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC. Adamantiades- Behçet's disease: serum IL-8 is a more reliable maker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 2000; 201:37-9.
17. Yamamoto T, Osaki T, Yoneda K, Ueta E. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J Oral Pathol Med 1994; 23:309-15.
18. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995; 104:784-8.
19. Popovic M, Stefanovic D, Pejnovic N et al. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis. Transplant Proc 1998; 30:4135-6.
20. Lewinski U, Mavligib G, Hersh E. Cellular immune modulation after a single high dose of levamisole in patients with carcinoma. Cancer 1980; 46:2185-94.
21. Janssen PA. The levamisole story. Prog Drug Res 1976; 20:347-83.
22. Redondo JM, Lopez-Guerrero JA, Fresno M. Potentiation of interleukin-2 activity by levamisole and imidazole. Immunol Lett 1978; 4:31-41.
23. Sun A, Chiang CP, Chiou PS et al. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus. J Oral Pathol Med 1994; 23:172-7.
24. Yamamoto T, Yoneda K, Ueta E et al. Serum cytokine levels in patients with oral mucous membrane disorder. J Oral Pathol Med 1991; 20:275-9.
25. Porat R, Poutsiaka DD, Miller LC et al. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 1992; 6:2482-6.
26. Kaplanski G, Porat R, Aiura K et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 1993; 81:2492-5.
27. Bickel M, Nothen SM, Freiburghaus K, Shire D. Chemokine expression in human oral keratinocyte cell lines and keratinized mucosa. J Dent Res 1996; 75:1827-34.
28. Agarwal S, Piesco NP, Johns LP, Riccelli AE. Differential expression of IL-1 beta, TNF-alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res 1995; 74:1057-65.
29. Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res 1997; 32:279-86.
30. Sandros J, Karlsson C, Lappin DF et al. Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection. J Dent Res 2000; 79:1808-14.
31. Sugiyama A, Uehara A, Iki K et al. Activation of human gingival epithelial cells by cell-surface components of black-pigmented bacteria: augmentation of production of interleukin-8, granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor and expression of intercellular adhesion molecules 1. J Med Microbiol 2002; 51:27-33.
32. Oido-Mori M, Rezzonico R, Wang PL et al. Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact. Infect Immun 2001; 69:4493-501.
33. Lai HM. A Randomized Controlled Intervention Trial for Periodontal Disease: Community-based Screening for Periodontal Disease. MPH Thesis. School of Public Health, National Taiwan University, 2003.
34. Sugermann PB, Savage NW, Seymour GJ, Walsh LJ. Is there a role for tumor necrosis factor-alpha (TNF-α) in oral lichen planus? J Oncol Pathol Med 1996; 25:219-24.